Artificial induction of donor-specific immune hyporesponsiveness remains the goal of transplantation immunology. Sultzberger in 1930 1 and Chase in 1946 2 demonstrated that prior feeding of an antigen promoted antigen-specific suppression of delayed-type hypersensitivity (DTH). Since then, several investigators have The aim of this study was to investigate the ability of portovenously administered donor antigens to induce immune hyporesponsiveness. Lewis (LEW, RT-1 l ) rats received Brown Norway (BN, RT-1 n ) rat donor splenocytes, via either the portal vein (PV group) or the peripheral vein (IV group). The immune responses of LEW rats, treated with either donor BN or third party Wistar King A (WKA, RT-1 k ) splenocytes were established by the persistence of donor dendritic cells (DCs) in the host liver measured using fluorescence microscopy and flow cytometry and by the mixed lymphocyte reaction (MLR). The effect of intravenous gadolinium chloride (GDCl 3 ) on the blockade of Kupffer cell function prior to portovenous administration of splenocytes was also assessed. The MLR response was strongly inhibited in a BN-restricted manner after portovenous administration of donor BN splenocytes, but not by venous nor by portovenous administration of WKA splenocytes. Immunosuppression was blocked by pretreatment with GDCl 3 . The percentage of donor DCs in hepatic non-parenchymal cells (NPCs) was significantly higher in the PV group compared with the IV group. Treatment with GDCl 3 decreased the percentage of donor DCs. In addition, cytotoxic T lymphocyte antigen 4 (CTLA4/ CD152), which may function as an immune attenuator, was strongly stained, and B7 was weakly stained in recipient liver in the PV group compared with the IV group. These results suggest that both donor DCs and recipient Kupffer cells (self DCs) are involved in the induction of immune hyporesponsiveness by donor cells. This occurs via portovenous administration, in which a signal of the CTLA4-B7 pathway played an important part in inhibiting the interaction of CD28 and its B7 ligands.
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reported the potential for alloantigen tolerance by portovenous injection of donor cells in animal models. 3 -7 However, the mechanism of this induction and maintenance of tolerance remains unclear, and specific tolerance has rarely been achieved in clinical transplantation. Various mechanisms have been proposed, including the presence of suppressor T cells, 8 serum suppressive factors, 9 preferential activation of T helper (Th)-2 cells 10,11 and enhanced prostaglandin-E2 production by Kupffer cells. 12 In the present study, we investigated whether or not portovenous administration of splenocytes induced donor-specific immune hyporesponsiveness. Their responses were examined by the mixed lymphocytes reaction (MLR). We also investigated the effect of intravenous administration of gadolinium chloride (GDCl 3 ), a blocker of Kupffer cell function, on the above responses. 13 The initiation of rejection of allogeneic grafts is principally mediated by alloantigenactivated T cells. 14, 15 In the context of alloreactivity, optimal activation of alloreactive T cells requires the receipt of two distinct, but synergistic, signals. The first signal is initiated by the interaction of the T-cell receptor (TCR) with the complex of the antigen major histocompatibility complex (MHC) molecules expressed on the surface of donor antigen-presenting cells (APCs). The second signal is a non-antigen-specific costimulation mediated by the interaction of CD28 on T cells with their B7 family ligands on the surface of APCs. CD28 shares its ligands (B7-1 and B7-2) with a related receptor (cytotoxic T lymphocyte antigen 4; CTLA4), which has been found to play a critical role in T-cell activation. 16, 17 Blockade of the CD28/B7 pathway by a soluble recombinant fusion protein of CTLA4 (CTLA4Ig) has been shown to provide negative signals that downmodulate a spectrum of T-cell-dependent immune responses. 17, 18 In vivo, CTLA4Ig treatment induces suppression of T-cellmediated immune responses, as well as antibody production to allogeneic and xenogeneic grafts. 19, 20 In the present study, we also examined the impact of CTLA4 signalling in immune hyporesponsiveness induction by donor splenocytes administered via the portal vein.
Materials and methods

ANIMALS
Male Brown-Norway (BN, RT-1 n ) rats and female Lewis (LEW, RT-1 l ) rats (7 -10 weeks of age) were used as donors and recipients, respectively. The animals were purchased from Charles River Laboratory (Japan). Male Wister King A (WKA, RT-1 k ) rats (7 -10 weeks of age) were used as third party and obtained from NIPPON SLC Inc. (Japan). All animals were kept under pyrogen-free conditions at the Animal Experimental Centre of Okayama University. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Okayama University Medical School.
The LEW rats were divided into the following four groups: the PV (BN) group, which received portovenous inoculation of BN splenocytes; the IV (BN) group, which received intravenous injection of BN splenocytes; the PV (WKA) group which received portovenous administration of WKA splenocytes; and the IV (WKA) group, which received intravenous injection of WKA splenocytes. Each group consisted of six rats.
PREPARATION OF SPLENOCYTES
Fresh spleens were harvested from BN or WKA rats under ether anaesthesia. Singlecell suspensions were prepared by passing the spleen through a 60-gauge stainless steel sieve. Red blood cells were lysed with K Nakagawa, T Matsuno, H Iwagaki et al.
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Tris-ammonium chloride buffer. Splenocyte suspensions were then washed twice with Hank's balanced salt solution and resuspended in RPMI-1640 medium at a concentration of 3 × 10 8 cells/ml. The viability of splenocytes was determined by the trypan blue dye exclusion test.
HISTOLOGICAL EXAMINATION AND FLOW CYTOMETRIC ANALYSIS OF DONOR SPLENOCYTES
Splenocytes from BN or WKA rats were labelled using PKH-26, fluorescent staining kit (Zynaxis, Malvern, PA, USA) for general membrane labelling, according to the method of Samlowski et al. 21 PKH-26 solution (5 × 10 -5 M) was added to the cell suspension. Splenocytes were resuspended in diluent C (Zynaxis, Malvern, PA, USA) at a concentration of 3 × 10 8 cells/ml. Stained splenocytes were then suspended in RPMI-1640 medium and injected at a volume of 0.5 ml/rat (1.5 × 10 8 cells/rat) into recipient LEW rats via the portal vein (PV group) or via a peripheral tail vein (IV group). Rats of both groups were killed either 3 days or 7 days after injection of splenocytes and liver specimens were obtained for histological and flow cytometric analysis.
For histological examination, the liver samples were frozen rapidly and stored at -80°C. Cryostat sections of 5 µm were prepared and examined using fluorescence microscopy (microscope model BHF, Olympus, Tokyo, Japan).
Flow cytometric analysis was performed to determine the proportion of PKH-26-positive cells among the mononuclear cells in the recipient liver. PKH-26, a membrane lipid bilayer-incorporated dye, provides long-term labelling for up to 15 days, and only minimally affects cellular function and homing. Hepatic mononuclear cells were first harvested by perfusion with collagenase, and then isolated from hepatocytes by metrizamide density gradient centrifugation, based on the method of Pilaro et al. 22 Singlecolour flow cytometric analysis was performed on a FACScan (Becton Dickinson, Mountain View, CA, USA) and the percentage of PKH-26-positive cells among hepatic mononuclear cells was calculated.
MIXED LYMPHOCYTE REACTION ASSAY
Stimulator cells comprising peripheral blood lymphocytes (PBL) obtained from control BN or LEW rats were treated with 5% mitomycin C (MMC, Kyowa Hakko Co., Tokyo, Japan) in RPMI-1640 medium at 37 ºC for 40 min. Responder cells consisted of PBLs from recipient LEW rats prepared at day 3, day 7 or day 14. The responder cells (3 × 10 5 / 100 µl/well) were cultured in 96-well flatbottomed plates in triplicate, with an equal number of MMC-treated stimulator cells. The plates were incubated at 37°C in 5% CO 2 for 4 days, then pulse-labelled for 20 -24 h with [ 3 H]thymidine (1 µCi/well) and harvested. Proliferation was assayed by [ 3 H]thymidine incorporation measured using a liquid scintillation counter (Aloka Co., Tokyo, Japan). The stimulation index (SI) was calculated using the following formula: 
GADOLINIUM CHLORIDE ADMINISTRATION
The LEW rats from the PV group were divided into two subgroups: group 1 (positive control) received portovenous injection of BN splenocytes without gadolinium chloride (GDCl 3 ) injection (PV group); and group 2 received portovenous injection of splenocytes after administration of GDCl 3 (PV-GD group). In the PV-GD group, 7 mg/kg GDCl 3 was K Nakagawa, T Matsuno, H Iwagaki et al.
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injected into the tail vein on 2 consecutive days before portovenous inoculation. Flow cytometric analysis and MLR assay were performed as described above.
IMMUNOHISTOCHEMICAL EXAMINATION
Cryostat sections of recipient liver were cut from quick-frozen tissues embedded in OCT compound (Miles, Elkhart, IN, USA) and mounted on silanized glass slides (Dako, Glostrup, Denmark). After fixation using 100% acetone at 4°C for 9 min, endogenous peroxidase was quenched with 0.5% periodic acid solution (Merck, Darmstadt, Germany) for 10 min and sections were blocked with 10% normal goat serum. The slides were incubated overnight at 4°C with anti-rabbit CD28 antibody (Pharmingen, San Diego, CA, USA), anti-rabbit CD152 (CTLA4) antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-CD80 (B7-1) antibody and anti-CD86 (B7-2) antibody (Pharmingen, San Diego, CA, USA) at 0.1 µg/ml in PBS containing 1% bovine serum albumin (BSA). Bound primary antibodies were visualized by the avidin-biotin complex immunoperoxidase method, using the Vectastain ABC Elite peroxidase kit and 3,3′diaminobenzidine as a chromogen (Vector Labs, Burlingame, CA, USA). Slides were counterstained with methyl green dye.
STATISTICAL ANALYSIS
All data were expressed as means ± SEM. Differences between groups were examined for statistical significance using Student's t-test. P-value of < 0.05 denoted statistical significance.
Results
PERSISTENCE RATE OF DONOR CELLS
Fluorescence-positive cells were detected in recipient LEW livers at day 3. These had cellular processes/pseudopodia-like structures and were distributed mainly in the periportal and mid-zonal areas of hepatic lobules (Fig. 1 ). The number of fluorescence-positive cells in the liver of the PV group was approximately triple that of the IV group (Fig. 1A) . A small number of fluorescence-positive cells was also detected at day 7 (data not shown). The viability of splenocytes was > 95%.
At day 3, a significantly (P < 0.01) higher percentage of PKH-26 positive cells was found in hepatic non-parenchymal cells (NPCs) in the PV (BN) group compared with the IV (BN) group (Fig. 1B) . The higher percentage of donor BN splenocytes in recipient liver in the PV (BN) group was blocked by intravenous injection of GDCl 3 before intraportal antigen administration. The persistence of donor splenocytes was not affected by WKA splenocyte administration via either the portal or peripheral vein. At day 7, no significant differences were found in any of the groups, although in all groups, PKH-26 positive cells were still detected in hepatic NPCs (Fig. 2 ).
MIXED LYMPHOCYTE REACTION
At day 3 in the PV group, the MLR was significantly suppressed compared with that at day 0 (control) (P < 0.01). In addition, the MLR in the PV (BN) group was significantly suppressed compared with the MLR in the IV (BN) group at both day 3 and day 7 (P < 0.05), although no statistical significance was observed between MLR at days 7 and 14 in the PV (BN) group and MLR in control. The significant inhibition of MLR in the PV (BN) group at both day 3 and day 7 was completely blocked by GDCl 3 treatment (Fig. 3 ). In addition, MLR response at day 3 was not inhibited by intravenous or portovenous administration of WKA splenocytes (data not shown). 
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IMMUNOHISTOCHEMICAL ANALYSIS
The expression of CTLA4 antigen in recipient liver at day 3 was stronger in the PV (BN) group than in the IV (BN) group. In contrast, the expression of B7-1 and B7-2 was weak in the PV (BN) group. No significant difference was found between the two groups in the expression of CD28 (Fig. 4 ). 
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Discussion
The major finding of this study was that portovenous administration of donor BN splenocytes suppressed the immune responses of recipient LEW rats in a BNrestricted manner, as evidenced by flow cytometric and MLR analyses. These results suggest that intraportal administration of antigens induces a specific immunosuppressive effect, which is consistent with previous studies. 3 -7 These studies demonstrated, first, that injection of allogeneic splenocytes into the portal vein suppresses alloreactive potentials in the DTH response in mice; and secondly, that intraportal inoculation of alloantigens prolongs cardiac and renal allograft survival in rats. 3 -7 These observations and the findings of this study suggest that antigenspecific pre-immunization via the portal vein prolongs graft survival. However, a pertinent but unresolved question remains as to the mechanisms by which portovenous immunization prolongs graft survival.
It is likely that the donor splenocytes observed in recipient liver were dendritic cells (DCs). Such cells are a consistent feature of the donor-derived leucocyte populations that persist indefinitely in the tissues of tolerant mouse or rat liver allograft recipients, 23, 24 as well as in patients in whom organ transplantation has been successful. 25, 26 In long-surviving tolerant rat liver allograft recipients, the persistence of donor MHC class II+ cells (i.e. DCs) has been linked to the absence of histopathological features of chronic rejection. 27 Persistence of donor-derived cells of the DC lineage may, therefore, play a key role in the avoidance of acute and chronic rejection. In addition, several recent reports support the hypothesis of tolerogenic activity of DCs in vivo. 28 -32 Flow cytometric analysis revealed that the percentage of donor splenocytes in recipient hepatic NPCs in the PV (BN) group at day 3 was significantly higher than that in the IV (BN) group at day 3. In contrast, at day 7, no statistically significant differences were found between these groups. No significant differences in the persistence of donor splenocytes were found between the PV (WKA) and IV (WKA) groups. These results demonstrate that the persistence of donor splenocytes by intraportal injection was significantly increased in a BN-restricted manner, indicating portovenous donorspecific immunosuppression. In the PV (BN) group but not in the IV (BN) group 2, MLR at day 3 was significantly suppressed compared with the MLR at day 0 (control). This is consistent with the observed persistence of donor splenocytes in recipient liver.
Based on the results of this study, it appears likely that the antigen recognition process by intraportal immunization is involved in the induction of immune hyporesponsiveness. Treatment with GDCl 3 , which is a blocker of Kupffer cell function, completely abolished the induction of hyporesponsiveness brought about by the intraportal administration of donor antigens. This is in agreement with previous reports which have shown that suppression of DTH responses by intraportal injection of antigens was blocked by prior administration of GDCl 3 . 33, 34 Intestinal venous drainage through the liver is a prerequisite for the induction of oral tolerance. 35 The tolerogenic potential of antigen feeding is abolished by portocaval transposition. 36 These findings suggest that the liver might play an important role in the induction of oral and portovenous hyporesponsiveness and tolerance.
One explanation for the efficacy of portovenous immunization in inducing K Nakagawa, T Matsuno, H Iwagaki et al.
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prolongation of graft survival, as reported previously, 3 -7 is that presentation of alloantigen on donor DCs within the hepatic environment leads to specific hyporesponsiveness, possibly in co-operation with recipient hepatic Kupffer cells. This hypothesis is strengthened by a recent report that antigen-presenting cells (APCs) isolated from recipients of portovenous immunization could adoptively transfer increased graft survival. 37 The immune response, assayed by proliferation/interleukin (IL)-2 cytokine production, of host splenocytes incubated with allogeneic DCs is decreased in the presence of hepatic NPCs syngeneic with the spleen responder cells. There is evidence that adoptive transfer of cells from such mixed cultures (donor DCs + host NPCs) increases graft survival in vivo and generates cells capable of regulating immune responses in vitro (as assayed by decreased IL-2 and simultaneously increased transforming growth factor [TGF]-β production). 37 Modulation of cell surface co-stimulator molecules (B7-1, B7-2 and CD40) on the surface of APCs and their co-ligands (CD28, CD40L and CTLA4) on T cells has been proposed as a means of regulating the development of immunity. It is clear that different APCs influence the development of different T-cell subsets. The expression of death-inducing ligands may also contribute to the tolerogenic potential of T cells via Fas/Fas-ligand-dependent apoptosis. Indeed, the previous reports demonstrated that hepatic DCs induced Fas/Fas-liganddependent apoptosis in CD4+ T cells 38 and were able to regulate the autocrine production of IL-2 necessary for proliferation in CD8+ T cells. 39 Further investigation is needed on the immunobiology of hepatic DCs, including the role of hepatic APCs in alloantigen recognition and presentation, the potential for tolerance induction and the influence of hepatic DCs on allograft survival.
The present study demonstrates increased expression of CTLA4 antigen and decreased expression of B7-1 and B7-2 in recipient liver immunized by donor splenocytes administered via the portal vein. This suggests that the induction of immune hyporesponsiveness by portovenous immunization is accompanied by the emergence in recipient liver of regulatory T cells and regulatory DCs, which express increased CTLA4 antigen and decreased B7-1 and B7-2, respectively. As described previously, the CD28 co-receptor, CTLA4, may cause immune attenuation and selective activation of CTLA4 inhibits the T-cell immune response. 14 -20 CTLA4 has been proposed as a requirement for anergy induction, and this is in agreement with our results. Deficiency of B7-1 and B7-2 has been shown to be consistent with DC tolerogenicity, both in allograft models 40 and in experimental autoimmune disease. 41 This is also consistent with the findings of this study. In addition to the capacity of APCs to induce allogeneic T-cell anergy, treatment of APCs with IL-10 inhibits the expression of costimulatory molecules, such as the B7 family. 42 The availability of two different sets of APCs, those derived from the donor and those from the recipient, is a fundamental feature that distinguishes graft rejection from other types of immune responses. In graft rejection, T-cell stimulation by donor APCs and self-APCs (presenting peptides of donor origin) has been called 'direct recognition' and 'indirect recognition', respectively. In contrast, the current observations suggest that both donor DCs and self-DCs are involved in the induction of immune hyporesponsiveness by donor cells via portovenous administration. A signal of CTLA4-B7 pathway appears to play an important role in the inhibition of the interaction of CD28 and its B7 ligands. This 
apparent paradox has led to recent detailed investigation of the immunobiology of DCs and other APCs within the liver, including studies of microenvironmental factors that can modify the function of these cells to confer immunological privilege on hepatic allografts. 43 These factors include TGF-β, IL-10, hepatocyte growth factor, insulin-like growth factor and granulocyte-macrophage colony-stimulating factor. 44, 45 In view of the fact that DCs play a pivotal role in transplant tolerance and immunity, it is tempting to speculate that any factors that regulate DC growth, maturation and function will affect allograft acceptance or rejection.
This research demonstrates clearly that immune hyporesponsiveness can be achieved by the infusion of donor-strain splenocytes via the portal vein. An area for further investigation would be the ex vivo manipulation of donor APCs, including genetic engineering, to augment their immune hyporesponsiveness. A variety of promising approaches, which have been shown to render DCs tolerogenic, include exposure to either IL-10, which inhibits costimulatory molecules expression, 42 or to CTLA4-Ig, 46 viral IL-10 47 or Fas-ligand, 38 which exhibit differential inhibitory effects on host defences and have already been shown to suppress allograft rejection. The liver, with its inherent capacity to produce stem cells and DCs and its tolerogenic potential, might be the most appropriate organ with which to embark on these studies.
